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PAT CONCEPTS FOR THE PROCESS MONITORING AND CONTROL OF CONTINUOUS BIOMANUFACTURING 
 
Anoushka Durve, Jeff Goby, Dr. Ying Zhu, Dr. Eike Zimmermann 
Boehringer Ingelheim Biopharma, Fremont, CA 
ECI ICB 2015, 2nd Conference on Integrated Continuous Biomanufacturing , Berkeley CA. Nov 1st-5th 2015. 
 I n t r o d u c t i o n  
• Process Analytical technologies (PAT) are a key component to fully leverage the success of continuous manufacturing.   
• The timely measurement of critical quality attributes and critical process parameters assures that the desired product quality is being consistently manufactured and non-conforming material being identified. PAT tools 
can be utilized to meet the expectations for in-process monitoring, and allows for identification and isolation of undesired in-process materials.  
• It further supports process development, as continuous and fast response of process to factor changes allows efficient experimentation and increases process understanding within the range of conditions studied during 
development. Ultimately, PAT will allow Real Time Release (RTR), reduce cost, timelines and manufacturing risk. 
ECI ICB 2015, 2nd Conference on Integrated Continuous Biomanufacturing, Berkley CA. Nov 1st-5th 2015. 
 
 
O n - l i n e  T i t e r  A n a l y s i s  o f  P e r m e a t e  
The PATROL® 
Process Analysis 
System from Waters 
is an on-line UPLC 
instrument, providing 
access to real-time, 
chromatographic-
quality analysis for in-
process samples. 
I n t e g r a t e d  P A T  C o n c e p t  f o r  B i o r e a c t o r  M o n i t o r i n g  
In this study, the PATROL® 
system was connected 
directly to the load feed-
stream  (HCCF permeate) of 
an ÄKTA chromatography 
system for continuous protein 
A (ProA) purification. 
Continuous sampling and 
monitoring of titer has been 
successfully demonstrated. 
CEX 
SEC 
AAA 
C o n t i n u o u s  L o w  p H  V i r u s  I n a c t i v a t i o n  
Example process (feed forward control) 
1. Measure pH at probe 1  result 
controls acid addition. 
2. Measure pH at probe 2  if pH good, 
flow through ≥1 hr. residence coil; if not, 
divert to waste. 
3. Add base. 
4. Measure pH at probe 3  if pH good, 
flow to AEX/CEX; if not, divert to waste. 
 
Though potentiometric pH probes are commonly used in downstream processes, the potential drawbacks of the need for 
periodic recalibration (with consequent risk of product stream contamination), susceptibility to human calibration error, 
and slow response time, are of concern for sterile, continuous manufacturing systems over long periods of time. Thus, 
we established POC of spectral pH measurement as an alternative approach as PAT application during low pH virus 
inactivation within the desired accuracy (±0.10). We researched chromophores that are on the FDA inactive ingredient list 
or GRAS list, UV absorbing,  colorless, and have pKa values in desired pH range. Ascorbic acid and thiamine met the 
requirements and gave a strong UV signal dependent on pH. The applied multivariate model showed ±0.07 pH accuracy 
in the 3.3-4.5 range.  
Perfusion 
Brx ProA V-I AEX CEX VRF UFDF 
 pH probe requirements: 
• 25 day process  system sterility required 
 probes sterility required 
• Should not need removal for maintenance, 
must tolerate SIP/CIP.  
• Fast response to add correct amount of 
inactivation acid. 
• Accuracy (± 0.10 in 3.0-3.8 range) over 
time to ensure adequate pH values. 
Bioreactor samples also pass through the Cell 
Removal System (CRS) by BEND Research for 
delivery of cell free samples to the Gilson 
fraction collector for further sample preparation, 
e.g. for AAA analysis or ProA purification. 
Retains can be collected for additional at-
line/offline analysis. POC for the integral part of 
the CRS and Gilson is on-going. 
Data 
Daily samples were drawn from bioreactors using the 
Modular Automated Sampling Technology (MAST) 
units by BEND Research. Bioreactor samples were 
directed to a NOVA Flex unit for online metabolite 
analyses. A god correlation to manual samples has 
been established. 
From here, the Waters PATROL®  system 
can perform on-line AAA analysis or PQ 
analysis of proA purified samples, e.g. 
SEC for size analysis or  CEX for charge 
variants. 
We are presenting an integrated PAT concept for the analysis of cell culture performance, titer and product quality parameters for bioreactor performance.  
Rapid mAb rise at 
neutral pH 
Rapid pH fall (~0.14 
pH per sec) 
Rapid mAb fall at pH 
3.5-5 
Data 
